Simple Pharma launches “CloudOps”, an integrated pharma operations as a service solution for pharmaceutical companies selling in Europe

London — 12 July 2022 — Simple Pharma begins providing Consilient Health with outsourcing distribution services for specialised product Ghryvelin® (macimorelin) across Europe.

Simple Pharma, a pharma operations service provider, has launched its “CloudOps” product with its first customer, Consilient Health. Tried and tested in-house with Simple Pharma’s sister company Androlabs, CloudOps is a solution designed for pharmaceutical companies by pharmaceutical companies with the purpose of minimising resources spent on setting up and managing operational infrastructure to distribute pharma products.

Consilient Health is a pharmaceutical company with a rich heritage of commercialising products in areas such as women’s health, endocrinology, bone health and urology in several European countries.

By plugging into Simple Pharma’s existing infrastructure, CloudOps customers can confidently hand over operational responsibility for their products. CloudOps assists with channel access in new territories, product launches, and demand forecasting, leaving pharmaceuticals companies with more time to focus on what’s important — their therapy areas and their patients. CloudOps is a new service offered by Simple Pharma, which is an addition to its core business of managing pharma products on behalf of commercial entities (“the best home for proven pharma products”).

Ghryvelin® (macimorelin) is available subject to local reimbursement across the EU.

If you would like to find out more about CloudOps, you can email the Simple Pharma team at contact@simplepharma.com.

--

--

The Pharma industry’s go-to operations and divestment partner.

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Simple Pharma

The Pharma industry’s go-to operations and divestment partner.